S&P 500
7,549.70
+0.95%
Dow Jones
52,538.20
+0.37%
Nasdaq 100
29,781.60
+1.93%
Russell 2000
2,994.98
+1.53%
FTSE 100
10,475.60
-0.37%
Nikkei 225
68,934.70
+1.86%

Investing

ASND logo Ascendis Pharma : ASND

Price Target $256 ↓7.8%
›

ASND

Stock Data

$276.94

Change down

$0.24 (0.09%)

Asset Type

Common Stock

Exchange

NASDAQ

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

BIOTECHNOLOGY

Ascendis Pharma A/S is a biopharmaceutical firm based in Hellerup, Denmark, founded in 2006. It specializes in creating innovative treatments for unmet medical needs, with a notable product, SKYTROFA, designed for individuals with growth hormone deficiency (GHD). Beyond SKYTROFA, Ascendis is actively working on a robust pipeline focused on rare endocrinology diseases and exploring new therapies in oncology.

All Ascendis Pharma Articles

1 Article